Middle East North Africa - Financial Network

Demand More is a registered trade mark of MENAFN.COM

 
  Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

USA Market Data: Bristol-Myers Squibb Co - BMY




Stock data

Last Trade  48.17 Trade Time  4/15/2014
Change   0.21 Volume (thou)   13265.2
%Change  .44% Last Trade Size  
Open  48.285 Bid  48.17
Today's High  48.48 Ask  48.18
Today's Low  47.4825 Size Bid/Ask  0 x0

Fundamental Data

Market Cap (mil)   79816341.24 52 Week High  57.49
Shrs Outstanding (thou)   1656972000 52 Week Low  39.18
EPS  1.54 PE Ratio  31.28
Volatility   Yield  2.99
Dividend Freq.  4 Ex-Dividend Date  4/2/2014
Dividend Amount  0.36 Exchange  NYSE
Delayed quotes powered by S&P comstock. All stock quotes are delayed by 20 minutes and are believed to be accurate but are not warranted or guaranteed by MENAFN.com

  Related News
Apr 14, 2014 FluoroPharma Appoints Dr. H. William Strauss, Internationally Recognized Expert in the Field of Cardiovascular Nuclear Medicine, to Chair the Scientific Advisory Board, Marketwire
Apr 10, 2014 Bristol-Myers Squibb presents Phase III data demonstrating that investigational all-oral daclatasvir and asunaprevir therapy achieved SVR(12) rates of up to 90% among broad range of genotype 1b hepatitis C patients, CNW Group
Apr 01, 2014 Theravance Appoints Kevin Kwok, Head of Talent Acquisition and Strategy, Marketwire
Mar 31, 2014 Innate Pharma SA begins Phase I trial with lirilumab and nivolumab in selected solid tumors under cohort expansion, M2
Mar 31, 2014 INNATE PHARMA : Start of cohort expansion of Phase I trial with lirilumab and nivolumab in selected solid tumors, GlobeNewswire
Mar 25, 2014 Five Prime Therapeutics Announces Fourth Quarter and Fiscal 2013 Financial Results, GlobeNewswire
Mar 19, 2014 Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway, GlobeNewswire
Mar 18, 2014 Asia-Pacific NSCLC Market Expected to Reach $2.9 billion by 2019, M2
Mar 17, 2014 Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways, GlobeNewswire
more...

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help